Literature DB >> 20686866

Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population.

Juraj Javor1, Stanislav Ferencik, Maria Bucova, Martina Stuchlikova, Emil Martinka, Lubomir Barak, Lujza Strbova, Hans Grosse-Wilde, Milan Buc.   

Abstract

Numerous cytokines have been shown to participate in the pathogenesis of type 1 diabetes (T1D). As gene polymorphisms can influence cytokine production or function, they may potentially contribute to genetic predisposition to the disease. The aim of this study was therefore to investigate the role of 22 single nucleotide polymorphisms (SNPs) in 13 cytokine and cytokine receptor genes in genetic susceptibility to T1D. Polymerase chain reaction with sequence-specific primers was used to genotype cytokine SNPs and HLA-DRB1 alleles in 151 diabetics and 140 healthy individuals of Slovak origin. Univariate analysis showed that transforming growth factor (TGF)-beta1 codon 10 TT homozygotes were significantly more susceptible to developing T1D than C allele carriers (P (c) = 0.0066, OR = 2.46). Furthermore, tumor necrosis factor (TNF)-alpha -308 A allele carriers were also significantly overrepresented among the diabetics (P (c) = 0.0031, OR = 2.62); however, the association of the -308 A allele with T1D might be due to its strong linkage disequilibrium with the susceptibility allele HLA-DRB1*0301. An association was also found with interleukin (IL)-6 -174 G/C and nt565 G/A SNPs; however, its significance was lost when statistical correction was applied. These data suggest that the TGF-beta1 codon 10 SNP is among numerous genetic variations with small individual effects on T1D development. Moreover, a possible role of TNF-alpha and IL-6 SNPs cannot be ruled out, although their association with T1D was due to strong LD with the HLA class II susceptibility allele or did not withstand statistical correction, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686866     DOI: 10.1007/s00005-010-0092-z

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  6 in total

1.  IL-6 gene rs1800795 polymorphism and diabetes mellitus: a comprehensive analysis involving 42,150 participants from a meta-analysis.

Authors:  Zhiying Cheng; Chunmin Zhang; Yuanyuan Mi
Journal:  Diabetol Metab Syndr       Date:  2022-07-15       Impact factor: 5.395

2.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

3.  Association of transforming growth factor-β1 polymorphisms with the risk of diabetes mellitus.

Authors:  Song Mao; Jianhua Zhang; Min Zhao; Yuan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens.

Authors:  Awad E Osman; Imad Brema; Alaa AlQurashi; Abdullah Al-Jurayyan; Benjamin Bradley; Muaawia A Hamza
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

5.  Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk.

Authors:  Maira Lr Curti; Milena M Pires; Camila R Barros; Antonela Siqueira-Catania; Marcelo Macedo Rogero; Sandra Rg Ferreira
Journal:  Diabetol Metab Syndr       Date:  2012-11-24       Impact factor: 3.320

Review 6.  The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis.

Authors:  Jean-Jacques Lebrun
Journal:  ISRN Mol Biol       Date:  2012-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.